The Massachusetts Institute of Technology (MIT) has made two changes in its holdings during the third quarter of this year that includes the purchase of Procept Biorobotics Corp PRCT — a surgical robotics company focused on advancing patient care.
According to its 13F filings, MIT bought 8,034 shares of the company at a valuation of $333,000. Shares of the company have gained over 8% in the last month. On Thursday, the company reported a total revenue of $20.3 million for the third quarter, registering an increase of 135% compared to the prior year period.
Also Read: Best Forex Brokers
However, the company’s net loss widened to $22.6 million in the third quarter, compared to a loss of $14.1 million in the same period last year. Procept has projected full-year revenue of approximately $72.5 million. This compares to previous revenue guidance of $66 million to $68 million, it said.
Sale: During the quarter, MIT offloaded over 19,000 shares of BOSTON OMAHA Corp BOC taking the valuation of its holdings down to $61.9 million, according to its 13F filings. Shares of the company have gained over 13% in the last month.
Holdings: MIT has just seven holdings according to its latest 13F filing. This includes Robinhood Markets Inc HOOD, Coupang Inc CPNG, Grab Holdings Ltd GRAB, Snowflake Inc SNOW, and Textron Inc. TXT.
Read Next: Alibaba, Nio Stocks Surge: Hang Seng Rises Over 3% As Tech, EV Rally Outweighs COVID-19 Worries
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.